美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

First Tracks Biotherapeutics Inc

36.44

-1.5400-4.05%

盤後：36.540.1000+0.27%19:43 EDT

成交量：62.00萬

成交額：2,250.95萬

市值：13.02億

市盈率：-8.04

高：38.30

開：38.08

低：35.49

收：37.98

52周最高：49.91

52周最低：14.72

股本：3,573.08萬

流通股本：3,474.88萬

量比：1.20

換手率：1.78%

股息：- -

股息率：- -

每股收益(TTM):-4.5296

淨資產收益率：-48.91%

總資產收益率：-28.97%

市淨率：7.71

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

美國研究綜述-愛彼迎、Five Below、Silgan Holdings

美國研究綜述-愛彼迎、Five Below、Silgan Holdings

富國銀行首次覆蓋First Tracks Biotherapeutics，給予「超配」評級及30美元目標價

First Tracks Biotherapeutics公布2026年第一季度財務業績並更新業務進展

First Tracks Biotherapeutics公司：售股股東或可出售高達10.5股普通股 - SEC文件披露

美國研究綜述-Alphabet、高露潔-棕欖、Welltower

Piper Sandler首予First Tracks Biotherapeutics增持評級目標價54美元

H.C. Wainwright首予First Tracks Biotherapeutics買入評級目標價30美元

Leerink Partners首次覆蓋First Tracks Biotherapeutics 給予"跑贏大盤"評級及46美元目標價

巴克萊首予First Tracks Biotherapeutics增持評級目標價40美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/TRAX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TRAX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAX\",,,,,undefined,":{"symbol":"TRAX","market":"US","secType":"STK","nameCN":"First Tracks Biotherapeutics Inc","latestPrice":36.44,"timestamp":1789156800000,"preClose":37.98,"halted":0,"volume":619972,"hourTrading":{"tag":"盘后","latestPrice":36.54,"preClose":36.44,"latestTime":"19:43 EDT","volume":5143,"amount":187421.68,"timestamp":1789170182408,"change":0.1,"changeRate":0.002744,"amplitude":0.002744},"delay":0,"changeRate":-0.04054765666140072,"floatShares":34748800,"shares":35730843,"eps":-4.529554,"marketStatus":"休市中","change":-1.54,"latestTime":"09-11 16:00:00 EDT","open":38.08,"high":38.295,"low":35.49,"amount":22509531.09462,"amplitude":0.073855,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.529554,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":37.98,"preHourTrading":{"tag":"盘前","latestPrice":37.98,"preClose":37.98,"latestTime":"06:03 EDT","volume":1,"amount":37.98,"timestamp":1789120988605,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":36.54,"preClose":36.44,"latestTime":"19:43 EDT","volume":5143,"amount":187421.68,"timestamp":1789170182408,"change":0.1,"changeRate":0.002744,"amplitude":0.002744},"volumeRatio":1.2006995339697915,"impliedVol":1.1566,"impliedVolPercentile":0.9651},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAX\",,,,,undefined,":{"symbol":"TRAX","floatShares":34748800,"roa":"-28.97%","roe":"-48.91%","lyrEps":0,"volumeRatio":1.2006995339697915,"shares":35730843,"dividePrice":0,"high":38.295,"amplitude":0.073855,"preClose":37.98,"low":35.49,"week52Low":14.72,"pbRate":"7.71","week52High":49.9114,"institutionHeld":0,"latestPrice":36.44,"eps":-4.529554,"divideRate":0,"volume":619972,"delay":0,"ttmEps":-4.529554,"open":38.08,"prevYearClose":20,"prevWeekClose":40.46,"prevMonthClose":41.84,"prevQuarterClose":20.12,"fiveDayClose":42.51,"twentyDayClose":44.03,"sixtyDayClose":17.14},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRAX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"TRAX","fiscalQuarterEnding":"2026/06","expectedEps":-0.74,"name":null,"time":"盤後","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.95}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRAX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRAX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1787112000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRAX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRAX","date":"2026-09-11","current":-8.044942,"percent":0.336842,"low":-10.141689,"twenty":-9.33927,"median":-4.366436,"eighty":-3.530954,"high":-3.156022,"avg":-6.13563,"sd":2.690622,"marketCap":1357057417},"quantilePoints":[{"date":"2026-04-24","current":-3.975194,"twenty":-3.975194,"median":-3.975194,"eighty":-3.975194,"marketCap":660227979},{"date":"2026-05-01","current":-4.868566,"twenty":-4.868566,"median":-4.085034,"eighty":-3.799448,"marketCap":808605530},{"date":"2026-05-08","current":-3.728313,"twenty":-4.68236,"median":-4.236719,"eighty":-3.799448,"marketCap":619224346},{"date":"2026-05-15","current":-3.799448,"twenty":-4.433387,"median":-4.031683,"eighty":-3.799448,"marketCap":631038952},{"date":"2026-05-22","current":-3.452672,"twenty":-4.299486,"median":-3.855938,"eighty":-3.664859,"marketCap":584796305},{"date":"2026-05-29","current":-3.259026,"twenty":-4.249272,"median":-3.799448,"eighty":-3.475745,"marketCap":551997467},{"date":"2026-06-05","current":-3.749322,"twenty":-4.203244,"median":-3.738817,"eighty":-3.411676,"marketCap":635041334},{"date":"2026-06-12","current":-3.508294,"twenty":-4.109513,"median":-3.726221,"eighty":-3.329068,"marketCap":594217248},{"date":"2026-06-18","current":-3.743141,"twenty":-4.020386,"median":-3.683399,"eighty":-3.361617,"marketCap":633994562},{"date":"2026-06-26","current":-3.372329,"twenty":-3.945066,"median":-3.663829,"eighty":-3.37851,"marketCap":571188276},{"date":"2026-07-02","current":-3.829664,"twenty":-3.955109,"median":-3.663829,"eighty":-3.376449,"marketCap":648649362},{"date":"2026-07-10","current":-6.674616,"twenty":-4.112294,"median":-3.726221,"eighty":-3.397462,"marketCap":1130513144},{"date":"2026-07-17","current":-7.459502,"twenty":-4.261943,"median":-3.735727,"eighty":-3.424655,"marketCap":1263453116},{"date":"2026-07-24","current":-7.754091,"twenty":-4.794084,"median":-3.774042,"eighty":-3.434543,"marketCap":1313349220},{"date":"2026-07-31","current":-9.842999,"twenty":-6.999282,"median":-3.799448,"eighty":-3.441135,"marketCap":1667157964},{"date":"2026-08-07","current":-9.334163,"twenty":-7.464446,"median":-3.842801,"eighty":-3.45844,"marketCap":1580973783},{"date":"2026-08-14","current":-9.814035,"twenty":-7.742967,"median":-3.975194,"eighty":-3.486045,"marketCap":1573229017},{"date":"2026-08-21","current":-9.33927,"twenty":-8.651869,"median":-4.081492,"eighty":-3.504998,"marketCap":1497122321},{"date":"2026-08-28","current":-9.97229,"twenty":-9.339073,"median":-4.144854,"eighty":-3.509324,"marketCap":1598597915},{"date":"2026-09-04","current":-9.475235,"twenty":-9.448042,"median":-4.257739,"eighty":-3.516946,"marketCap":1518918135},{"date":"2026-09-11","current":-8.465524,"twenty":-9.33927,"median":-4.366436,"eighty":-3.530954,"marketCap":1357057417}],"updateTime":1789264129020},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRAX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659713954","title":"美國研究綜述-愛彼迎、Five Below、Silgan Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2659713954","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659713954?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 14:50","pubTimestamp":1786603808,"startTime":"0","endTime":"0","summary":"美国研究综述-爱彼迎、Five Below、Silgan Holdings路透8月13日-周四，华尔街证券分析师下调了多家在美国上市公司的评级和目标股价，其中包括爱彼迎、Five Below和Silgan Holdings。股票按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL4S44A0GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMRZ","Z","ABNB","LLII","TRAX","UNCY","ALGM","ARMK","MTSI","BOAT","FLYT","NURE","SPHR","LOW","MSGE","ZG","FIVE","KURA","ANRO","SRRK","LQDA","RHP","OSCR","DUOL","EAT","PARK","ELIS","HP","IBRN","AMTM","FLY","MNPR","OI","TRIP","INO","CAH","OZEM","PAYX","CSCO","MNSH","CYTK","SLGN","LLY","OII","ACM","CURE","INSW","PTCT","YELP","COHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659139540","title":"美國研究綜述-愛彼迎、Five Below、Silgan Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2659139540","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659139540?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 14:50","pubTimestamp":1786603808,"startTime":"0","endTime":"0","summary":"美国研究综述-爱彼迎、Five Below、Silgan Holdings路透8月13日-周四，华尔街证券分析师下调了多家在美国上市公司的评级和目标股价，其中包括爱彼迎、Five Below和Silgan Holdings。股票按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL4T44A0GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHP","MSGE","MNPR","AMRZ","ANRO","LQDA","KURA","AMTM","LLY","MNSH","LOW","COHX","OSCR","PTCT","CSCO","XES","Z","FLY","YELP","PAYX","SLGN","EAT","PARK","OI","ABNB","CYTK","HP","ALGM","SRRK","CAH","UNCY","TRUH","SPHR","INO","TRIP","TRAX","AGNG","HRTS","ZG","ILDR","DUOL","COHR","OII","ACM","INSW","ARMK","IHE","IXJ","MTSI","FIVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160045773","title":"富國銀行首次覆蓋First Tracks Biotherapeutics，給予「超配」評級及30美元目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=1160045773","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160045773?lang=zh_tw&edition=fundamental","pubTime":"2026-06-08 18:46","pubTimestamp":1780915574,"startTime":"0","endTime":"0","summary":"富国银行分析师团队启动了对生物制药公司First Tracks Biotherapeutics Inc.的研究覆盖，并给予其股票“超配”评级。该行同时设定了30美元的目标股价，预示着分析师认为该公司股票在当前水平上具有显著的上行潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102003350","title":"First Tracks Biotherapeutics公布2026年第一季度財務業績並更新業務進展","url":"https://stock-news.laohu8.com/highlight/detail?id=1102003350","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102003350?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 04:16","pubTimestamp":1778789777,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics Inc. 近日公布了其截至2026年第一季度的财务业绩，并向市场同步更新了公司最新的业务动态。此次发布涵盖了公司在关键研发项目上的推进情况、管线布局的调整以及未来的战略规划，旨在为投资者提供全面的运营视角。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137960030","title":"First Tracks Biotherapeutics公司：售股股東或可出售高達10.5股普通股 - SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1137960030","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137960030?lang=zh_tw&edition=fundamental","pubTime":"2026-05-09 04:40","pubTimestamp":1778272801,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会的一份文件显示，First Tracks Biotherapeutics Inc的现有售股股东，可能将出售高达10.5股公司普通股。\n这份文件揭示了股东潜在的股份出售计划，相关信息已按监管要求进行备案。具体细节可在相关SEC文件中查阅。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632818936","title":"美國研究綜述-Alphabet、高露潔-棕欖、Welltower","url":"https://stock-news.laohu8.com/highlight/detail?id=2632818936","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632818936?lang=zh_tw&edition=fundamental","pubTime":"2026-05-04 15:35","pubTimestamp":1777880141,"startTime":"0","endTime":"0","summary":"美国研究综述-Alphabet、高露洁-棕榄、Welltower路透5月4日 - 周一，华尔街的证券分析师们调整了多家在美国上市公司的评级和目标股价，其中包括Alphabet、高露洁-棕榄和Welltower。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL4T41H0EI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["META","DAVE","BOBS","AAPD","KEX","CBOE","BTSG","ACA","AMZZ","ESPR","AAPL","FTAI","AAPU","FLS","MSFT","DAR","CSGP","AAPX","LEA","SAM","AX","BLDR","AAPY","DECK","AAPW","MLM","CORZ","CHD","MTZ","AAPB","MTCH","AMZY","EL","ETSY","AXSM","CL","AMP","WELL","CAH","AMZU","HSY","APLY","FICO","ESS","TRAX","AMZN","GOOGL","CNC","AMGN","GDDY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166118707","title":"Piper Sandler首予First Tracks Biotherapeutics增持評級 目標價54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1166118707","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166118707?lang=zh_tw&edition=fundamental","pubTime":"2026-05-04 11:36","pubTimestamp":1777865787,"startTime":"0","endTime":"0","summary":"投行Piper Sandler首次覆盖生物技术公司First Tracks Biotherapeutics，给予\"增持\"评级，并设定54美元的目标股价。\n该评级反映出分析师对该公司研发管线前景的乐观预期。目标价的设定基于对其创新疗法的估值评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137187617","title":"H.C. Wainwright首予First Tracks Biotherapeutics買入評級 目標價30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1137187617","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137187617?lang=zh_tw&edition=fundamental","pubTime":"2026-04-28 18:13","pubTimestamp":1777371189,"startTime":"0","endTime":"0","summary":"生物制药公司First Tracks Biotherapeutics Inc获得投资机构H.C. Wainwright的首次覆盖，该机构给予其\"买入\"评级，并将目标股价设定为30美元。\n此次覆盖标志着华尔街对这家专注于创新疗法开发的生物技术企业投下信任票。分析师在研报中指出，公司核心研发管线具备显著商业化潜力，其专利技术平台在靶向治疗领域展现出独特优势。\n目标价格的设定反映了机构对公司长期价值增长空间的乐观预期。若股价能达到该目标位，较当前交易水平将存在可观上涨空间。市场关注点将集中于公司后续临床进展及合作伙伴关系拓展等关键催化剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150338315","title":"Leerink Partners首次覆蓋First Tracks Biotherapeutics 給予\"跑贏大盤\"評級及46美元目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=1150338315","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150338315?lang=zh_tw&edition=fundamental","pubTime":"2026-04-24 18:10","pubTimestamp":1777025447,"startTime":"0","endTime":"0","summary":"生物制药新锐First Tracks Biotherapeutics Inc迎来资本市场重要里程碑——知名投行Leerink Partners今日发布首份覆盖报告，给予该公司\"跑赢大盘\"的积极评级。这份覆盖报告的发布，标志着专业投资机构对First Tracks Biotherapeutics研发管线与商业前景的正式认可。Leerink Partners作为医疗健康领域的顶尖投行，其评级动向往往引发市场高度关注。随着创新药企融资环境逐步改善，具备差异化技术平台的First Tracks Biotherapeutics有望借助资本市场的东风，加速其前沿疗法的临床开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148679757","title":"巴克萊首予First Tracks Biotherapeutics增持評級 目標價40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1148679757","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148679757?lang=zh_tw&edition=fundamental","pubTime":"2026-04-22 18:39","pubTimestamp":1776854355,"startTime":"0","endTime":"0","summary":"巴克莱集团宣布首次覆盖生物制药公司First Tracks Biotherapeutics，并给予\"增持\"评级。该机构同时设定了40美元的目标股价，显示出对该公司未来发展潜力的积极展望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}